HK1097181A1 - Interferon-beta for anti-virus therapy for respiratory diseases - Google Patents
Interferon-beta for anti-virus therapy for respiratory diseasesInfo
- Publication number
- HK1097181A1 HK1097181A1 HK07104017.4A HK07104017A HK1097181A1 HK 1097181 A1 HK1097181 A1 HK 1097181A1 HK 07104017 A HK07104017 A HK 07104017A HK 1097181 A1 HK1097181 A1 HK 1097181A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- agent
- interferon
- beta
- respiratory diseases
- virus therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0405634.7A GB0405634D0 (en) | 2004-03-12 | 2004-03-12 | Anti-virus therapy for respiratory diseases |
PCT/GB2005/050031 WO2005087253A2 (fr) | 2004-03-12 | 2005-03-07 | Therapie antivirus pour le traitement de maladies respiratoires |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1097181A1 true HK1097181A1 (en) | 2007-06-22 |
Family
ID=32117582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07104017.4A HK1097181A1 (en) | 2004-03-12 | 2007-04-20 | Interferon-beta for anti-virus therapy for respiratory diseases |
Country Status (13)
Country | Link |
---|---|
US (3) | US7569216B2 (fr) |
EP (2) | EP1734987B1 (fr) |
JP (2) | JP4807526B2 (fr) |
AT (1) | ATE466591T1 (fr) |
CA (2) | CA2558212C (fr) |
DE (1) | DE602005021078D1 (fr) |
DK (1) | DK1734987T3 (fr) |
ES (1) | ES2343732T3 (fr) |
GB (1) | GB0405634D0 (fr) |
HK (1) | HK1097181A1 (fr) |
PL (1) | PL1734987T3 (fr) |
PT (1) | PT1734987E (fr) |
WO (1) | WO2005087253A2 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0405634D0 (en) | 2004-03-12 | 2004-04-21 | Univ Southampton | Anti-virus therapy for respiratory diseases |
US8318423B2 (en) * | 2004-07-06 | 2012-11-27 | Focus Diagnostics, Inc. | Methods and compositions for detecting rhinoviruses |
JP5172679B2 (ja) * | 2005-09-09 | 2013-03-27 | インペリアル イノベーションズ リミテッド | 呼吸器疾患の治療のためのインターフェロン−λ療法 |
BRPI0520564A2 (pt) * | 2005-09-20 | 2009-05-19 | Univ New York | método de tratar doença pulmonar com interferons apoio governamental |
DE102006022877B4 (de) | 2006-05-15 | 2009-01-29 | Sartorius Stedim Biotech Gmbh | Verfahren zur Bestimmung der Viabilität von Zellen in Zellkulturen |
US7871603B2 (en) | 2007-05-18 | 2011-01-18 | Synairgen Research Limited | Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly |
GB0713402D0 (en) * | 2007-07-11 | 2007-08-22 | Cardiff & Vale Nhs Trust | A method of diagnosing a condition using a neural network |
EP2220115A2 (fr) * | 2007-12-13 | 2010-08-25 | Glaxo Group Limited | Polypeptides, domaines variables d'anticorps et antagonistes |
CA2744947A1 (fr) * | 2008-12-19 | 2010-10-28 | The Regents Of The University Of California | Utilisation d'inhibiteurs du facteur de croissance epidermique dans le cadre du traitement d'une infection virale |
CA2782512A1 (fr) * | 2009-12-02 | 2011-06-09 | Neetour Medical Ltd. | Surveillance basee sur l'hemodynamie et evaluation d'une affection respiratoire |
JP5926200B2 (ja) * | 2010-03-12 | 2016-05-25 | シナーゲン リサーチ リミティッド | インフルエンザ様疾患の治療 |
DK2618842T3 (da) | 2010-09-22 | 2019-07-01 | Ena Therapeutics Pty Ltd | Hidtil ukendt immunstimulerende fremgangsmåde |
JP6730926B2 (ja) | 2014-01-08 | 2020-07-29 | プロージット ソウル バイオテクノロジー (ベイジン) カンパニー リミテッド | 融合ポリペプチドおよび使用方法 |
JP7317796B2 (ja) * | 2017-07-24 | 2023-07-31 | ノババックス,インコーポレイテッド | 呼吸器疾患を治療するための方法および組成物 |
US20220233643A1 (en) * | 2019-02-13 | 2022-07-28 | University Of Florida Research Foundation, Incorporated | TARGETING LUNG-RESIDENT TNFR2+ cDC2 (R2D2) SUBPOPULATION TO TREAT ASTHMA |
CN114174260A (zh) | 2019-06-26 | 2022-03-11 | 阿克塞利阿肿瘤学私人有限公司 | 新型分子 |
EP4181944A1 (fr) | 2020-07-20 | 2023-05-24 | Synairgen Research Limited | Interférons-bêta inhalés pour améliorer le résultat chez des patients infectés par sras-cov-2 |
GB202014114D0 (en) | 2020-09-08 | 2020-10-21 | Synairgen Res Ltd | Use of inhaled interferon-beta to treat virus-induced exacerbations in copd patients undergoing treatment with a systemic corticosteroid |
EP4240396A1 (fr) * | 2020-11-04 | 2023-09-13 | Ethris GmbH | Utilisation d'arnm de l'ifn-lambda pour le traitement d'infections virales |
WO2022154542A1 (fr) * | 2021-01-13 | 2022-07-21 | 에이비온 주식회사 | Méthode d'administration prophylactique contre un virus respiratoire, comprenant l'administration d'interféron bêta à un sujet potentiellement infecté par un virus respiratoire |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6596260B1 (en) * | 1993-08-27 | 2003-07-22 | Novartis Corporation | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
KR100384353B1 (ko) * | 1994-05-18 | 2003-10-04 | 네크타르 테라퓨틱스 | 인터페론의건조분말제형을제조하기위한방법및조성물 |
US6030609A (en) | 1995-05-19 | 2000-02-29 | Case Western Reserve University | Method and composition for treating paramyxovirus |
US20010031253A1 (en) * | 1996-07-24 | 2001-10-18 | Gruenberg Micheal L. | Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
AU780270B2 (en) * | 2000-02-23 | 2005-03-10 | Association Francaise Contre Les Myopathies | Treatment of immune diseases |
GB2362884A (en) | 2000-05-30 | 2001-12-05 | Isis Innovation | Extended duration of airway gene therapy |
WO2002036628A2 (fr) | 2000-11-02 | 2002-05-10 | Maxygen Aps | Nouveaux polypeptides $g(b) interferon multimeres |
AU2002254174A1 (en) * | 2001-03-13 | 2002-09-24 | Vical Incorporated | Interferon-beta polynucleotide therapy for autoimmune and inflammatory diseases |
AU2003215136A1 (en) | 2002-02-08 | 2003-09-02 | University Of Medicine And Dentistry Of New Jersey | Ifn-a/b-independent mechanism of antiviral protection |
US20040037809A1 (en) * | 2002-06-28 | 2004-02-26 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of interferon beta |
CA2503305A1 (fr) | 2002-10-23 | 2004-05-06 | Zymogenetics, Inc. | Procedes de traitement d'infection virale a l'aide de il-28 et il-29 |
WO2005023862A2 (fr) | 2003-08-07 | 2005-03-17 | Zymogenetics, Inc. | Preparations homogenes d'il-28 et d'il-29 |
GB0405634D0 (en) | 2004-03-12 | 2004-04-21 | Univ Southampton | Anti-virus therapy for respiratory diseases |
US20050244423A1 (en) | 2004-04-02 | 2005-11-03 | Klucher Kevin M | Methods for treating viral infection using IL-28 and IL-29 cysteine mutants |
-
2004
- 2004-03-12 GB GBGB0405634.7A patent/GB0405634D0/en not_active Ceased
-
2005
- 2005-03-07 JP JP2007502414A patent/JP4807526B2/ja not_active Expired - Fee Related
- 2005-03-07 PL PL05708482T patent/PL1734987T3/pl unknown
- 2005-03-07 EP EP05708482A patent/EP1734987B1/fr active Active
- 2005-03-07 DK DK05708482.4T patent/DK1734987T3/da active
- 2005-03-07 AT AT05708482T patent/ATE466591T1/de active
- 2005-03-07 CA CA2558212A patent/CA2558212C/fr active Active
- 2005-03-07 EP EP10161661A patent/EP2206512A3/fr not_active Withdrawn
- 2005-03-07 CA CA2787978A patent/CA2787978A1/fr not_active Abandoned
- 2005-03-07 PT PT05708482T patent/PT1734987E/pt unknown
- 2005-03-07 WO PCT/GB2005/050031 patent/WO2005087253A2/fr not_active Application Discontinuation
- 2005-03-07 ES ES05708482T patent/ES2343732T3/es active Active
- 2005-03-07 DE DE602005021078T patent/DE602005021078D1/de active Active
-
2006
- 2006-09-08 US US11/517,763 patent/US7569216B2/en active Active
-
2007
- 2007-04-20 HK HK07104017.4A patent/HK1097181A1/xx not_active IP Right Cessation
-
2009
- 2009-06-18 US US12/487,563 patent/US8273342B2/en active Active
-
2011
- 2011-04-20 JP JP2011093677A patent/JP2011144201A/ja active Pending
-
2012
- 2012-08-16 US US13/587,752 patent/US9089535B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2558212A1 (fr) | 2005-09-22 |
DE602005021078D1 (de) | 2010-06-17 |
US20070134763A1 (en) | 2007-06-14 |
WO2005087253A2 (fr) | 2005-09-22 |
DK1734987T3 (da) | 2010-08-30 |
GB0405634D0 (en) | 2004-04-21 |
ES2343732T3 (es) | 2010-08-09 |
EP1734987B1 (fr) | 2010-05-05 |
US8273342B2 (en) | 2012-09-25 |
CA2787978A1 (fr) | 2005-09-22 |
PT1734987E (pt) | 2010-07-06 |
EP2206512A2 (fr) | 2010-07-14 |
US7569216B2 (en) | 2009-08-04 |
US9089535B2 (en) | 2015-07-28 |
JP2007528890A (ja) | 2007-10-18 |
JP4807526B2 (ja) | 2011-11-02 |
CA2558212C (fr) | 2012-11-27 |
JP2011144201A (ja) | 2011-07-28 |
EP2206512A3 (fr) | 2013-01-09 |
US20090257980A1 (en) | 2009-10-15 |
WO2005087253A3 (fr) | 2005-11-24 |
PL1734987T3 (pl) | 2010-10-29 |
ATE466591T1 (de) | 2010-05-15 |
EP1734987A2 (fr) | 2006-12-27 |
US20130209399A1 (en) | 2013-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1097181A1 (en) | Interferon-beta for anti-virus therapy for respiratory diseases | |
PL1718336T3 (pl) | Nowe połączenie środków antycholinergicznych i beta-mimetyków do leczenia chorób układu oddechowego | |
RS20050484A (en) | Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate | |
AP1712A (en) | Novel tiotropium-containing inhalation powder | |
WO2007109118A3 (fr) | Procédés et compositions de réduction d'influx neutrophile et de traitement de dysplasie broncho-pulmonaire, de syndrome de détresse respiratoire, de maladie pulmonaire chronique, de fibrose pulmonaire, d'asthme et de maladie pulmonaire obstructive chronique | |
DE602005026007D1 (de) | Opioide zur behandlung von chronisch-obstruktiver lungenerkrankung (copd) | |
ATE421325T1 (de) | Kombination von methylxanthinverbindungen und steroiden zur behandlung chronischer atemwegserkrankungen | |
MY146628A (en) | Novel crystalline anhydride with anticholinergic effect | |
AU2002316771A1 (en) | Guanylate-cyclase c ligand, administered via the airways, for the treatment of respiratory airway problems | |
CY1108420T1 (el) | Προτοτυπο τιοτροπιουχο κονιωδες σκευασμα για εισπνοη | |
HK1116095A1 (en) | A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma. | |
SG149876A1 (en) | Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same | |
NO20073909L (no) | Forstover-formulering | |
EA200701077A1 (ru) | Применение конъюгатов липидов при лечении заболеваний | |
RS20060292A (en) | Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same | |
WO2007035879A3 (fr) | Combinaison de produits pharmaceutiques a base de s-nitrosothiol pour retablir un rythme respiratoire normal | |
IL189182A0 (en) | A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma | |
MXPA04007294A (es) | Composicion para inhalacion. | |
MXPA04002401A (es) | Nuevos medicamentos para inhalacion. | |
WO2005007134A8 (fr) | Compositions pulverulentes pour l'inhalation, contenant un nouvel agent anticholinergique | |
Miller | Combined inhaled bronchodilators in COPD | |
WO2003105907A3 (fr) | Compositions pour le transport de molecules therapeutiques dans les poumons, et leur utilisation pour leur traitement des cancers du poumon et des maladies pulmonaires | |
ZA200801408B (en) | A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (COPD) and asthma | |
ZA200801407B (en) | A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (COPD) and asthma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230304 |